In Heart Failure, Initial ICU Care by Cardiologist Differs by Race

Share this content:
In Heart Failure, Initial ICU Care by Cardiologist Differs by Race
In Heart Failure, Initial ICU Care by Cardiologist Differs by Race

WEDNESDAY, May 2, 2018 (HealthDay News) -- Among heart failure patients admitted to the intensive care unit (ICU), African-Americans are less likely than Caucasians to receive primary care by a cardiologist, according to a study published in the May 1 issue of JACC: Heart Failure.

Khadijah Breathett, M.D., from the University of Arizona in Tucson, and colleagues used data from the Premier database to identify 104,835 adult patients admitted to an ICU (2010 to 2014) with a primary discharge diagnosis of heart failure. Associations between race and primary ICU care by a cardiologist were determined.

The researchers found that 80.3 percent of patients were Caucasian and 19.7 percent were African-American. Compared to African-Americans, Caucasians had higher odds of care by a cardiologist (adjusted odds ratio, 1.42). Primary ICU care by a cardiologist was associated with higher in-hospital survival (adjusted hazard ratio, 1.2) compared with care by a non-cardiologist. Survival likelihood did not differ by patient race.

"Interventions that reduce racial differences in receipt of care and improve quality of care by non-cardiologists during ICU admissions for heart failure are indicated," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »